Shell Asset Management’s Abiomed Inc ABMD Stock Holding History

Shell Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-650	Closed	-$203K	–	1518
2021 Q2	$203K	Buy	650 +402	+162%	+$123K	﹤0.01%	1229
2021 Q1	$79K	Sell	248 -125	-34%	-$40K	﹤0.01%	1330
2020 Q4	$121K	Hold	373	–	–	﹤0.01%	1242
2020 Q3	$103K	Hold	373	–	–	﹤0.01%	1165
2020 Q2	$90K	Sell	373 -1,279	-77%	-$257K	﹤0.01%	1173
2020 Q1	$240K	Hold	1,652	–	–	0.01%	951
2019 Q4	$282K	Sell	1,652 -839	-34%	-$156K	0.01%	1070
2019 Q3	$443K	Hold	2,491	–	–	0.01%	961
2019 Q2	$649K	Sell	2,491 -3,011	-55%	-$799K	0.01%	789
2019 Q1	$1.57M	Hold	5,502	–	–	0.03%	398
2018 Q4	$1.79M	Sell	5,502 -972	-15%	-$338K	0.04%	351
2018 Q3	$2.91M	Sell	6,474 -406	-6%	-$160K	0.06%	315
2018 Q2	$2.81M	Buy	6,880 +3,391	+97%	+$1.23M	0.06%	340
2018 Q1	$1.01M	Buy	+3,489	New	+$884K	0.02%	656
2016 Q4	–	Sell	-4,699	Closed	-$604K	–	1102
2016 Q3	$604K	Buy	+4,699	New	+$563K	0.01%	795

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Shell Asset Management's ABMD Position: Q3 2021 in Review

Shell Asset Management sold out of Abiomed Inc (ABMD) in Q3 2021, closing a stake of 650 shares — an estimated $203K sold.

Shell Asset Management first reported a position in ABMD in Q3 2016 and held it in 15 quarters. The position peaked at $2.91M in Q3 2018. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2021.

Shell Asset Management reported no remaining Abiomed Inc position as of Q3 2021 after selling out during the quarter.
Shell Asset Management sold 650 Abiomed Inc shares in Q3 2021, an estimated $203K.
Shell Asset Management first reported a position in Abiomed Inc in Q3 2016 and held it in 15 quarters.
Shell Asset Management's Abiomed Inc position peaked at $2.91M in Q3 2018.
498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2021.

Based on Shell Asset Management's 13F filing for Q3 2021, filed 4 Nov 2021.